About this event:
Premenstrual Dysphoric Disorder (PMDD) is a severe cyclical mood disorder affecting up to 8% of women and people assigned female at birth. Characterised by intense emotional, cognitive, and physical symptoms in the luteal phase of the menstrual cycle, PMDD remains one of the most under-recognised and under-treated conditions in women’s health.
As psychedelic research continues to expand, there is growing interest in how these compounds may influence hormonal, emotional, and neural regulation — and what this might mean for those living with PMDD.
This webinar will bring together leading researchers and practitioners to explore the emerging science of psychedelics and PMDD, addressing key questions around neuroendocrine mechanisms, emotional processing, and therapeutic potential.
The event will include:
🧠 Presentation by Dr. Grace Blest-Hopley – an overview of current research on female biology, hormones, and psychedelic science.
💬 Panel discussion featuring experts in women’s mental health and psychedelic research.
🌸 Community Q&A session – an open conversation inviting audience reflections and questions.
This event aims to foster a nuanced discussion on the intersection of women’s health, hormonal cycles, and psychedelic medicine — highlighting both the possibilities and the scientific unknowns.
🔹 This is an educational event only. No medical or clinical advice can be provided.